by Truveta Research | Sep 9, 2026 | Featured research, Research
Pain medication use was nearly universal in the hospital, with more than 9 in 10 C-sections including acetaminophen, an NSAID, and an opioid. After discharge, NSAIDs and opioids were prescribed after about 6 in 10 C-sections and acetaminophen after about half. The...
by Truveta Research | Sep 1, 2026 | Featured research, Research
The rate of infants not receiving vitamin K injections at birth has increased in recent years, accelerating in 2025 and 2026. In January 2026, 5.2% of births did not have documented receipt of vitamin K, increasing to 8.1% in June 2026, a 57.4% increase. Rates of...
by Truveta Research | Aug 25, 2026 | Featured research, Research
July 2026 marked the largest month-to-month increase in GLP-1 prescribing among adults aged 65 years and older observed during the study period. AOM tirzepatide and AOM semaglutide showed the largest gains following launch of the Medicare GLP-1 Bridge, increasing...
by Truveta Research | Jul 30, 2026 | Featured research, Research
During July 2026, the rate of cyclosporiasis diagnosis reached 10.5 per 100,000 people with a healthcare encounter, more than 11-fold higher than the average July rate observed between 2018 and 2025 (0.9 per 100,000). More than 1 in 5 patients with a cyclosporiasis...
